ScholarWorks@Dongguk University

Journal of Crohn's and Colitis

Journal Title

  • Journal of Crohn's and Colitis

ISSN

  • E 1876-4479 | P 1873-9946

Publisher

  • Elsevier Science

Listed on(Coverage)

JCR 2008-2023
SJR 2008-2020;2022-2023
CiteScore 2011-2023
SCIE 2010-2024
CC 2016-2024
SCOPUS 2017-2024
MEDLINE 2016-2024
EMBASE 2016-2024

Active

  • Active

    based on the information

    • SCOPUS:2024-10

Country

  • ENGLAND

Aime & Scopes

  • The Journal of Crohn's and Colitis (JCC) is the official journal of the European Crohn's and Colitis Organisation (ECCO) and is concerned with the dissemination of knowledge on clinical, basic science and innovative methods related to Inflammatory Bowel Diseases.

Homepage

Article List

1 - 8 out of 8 results.

SCIESCOPUS
Treatment Experiences, Physician Communication, and Unmet Needs Among Patients With Inflammatory Bowel Disease in Koreaopen access

Kim, Y. S.; Kim, S.; Oh, D. J.; Jung, S. A.

ArticleIssue Date2026CitationJournal of Crohn's and Colitis, v.20, no.SupplementPublisherOxford University Press
SCIE
Long-term Efficacy and Persistence of Subcutaneous Infliximab after Switching from Intravenous Infliximab in patients with Crohn's disease: A Real-World Multicenter Prospective Cohort Study in Korea

Kim, K.; Hong, S. N.; Kang, S. B.; Lee, K. M.; Koo, J. S.; Jung, Y.; Yoon, H.; Lee, B. J.; Lee, H. S.; Lee, Y. J., et al.

ArticleIssue Date2025CitationJournal of Crohn's and Colitis, v.19, no.Supplement, pp i1466 - i1467PublisherOxford University Press
SCIESCOPUS
Clinical efficacy and durability of subcutaneous infliximab in patients with moderate-to-severe inflammatory bowel disease : a real-world data from a Korean multicentre prospective cohort study

Kim, K.; Hong, S. N. H.; Kang, S. B. K.; Lee, K. M.; Koo, J. S. K.; Jung, Y.; Lee, B. J. L.; Yoon, H. Y.; Kim, H. W.; Lim, Y. J., et al.

ArticleIssue Date2024CitationJournal of Crohn's and Colitis, v.18, no.Supplement, pp I1410 - I1412PublisherOxford University Press
SCIESCOPUS
Clinical efficacy and durability of subcutaneous infliximab in patients with inflammatory bowel disease after switching from intravenous in a Korean multicenter prospective cohort study

Kim, K.; Hong, S. N.; Kang, S. B.; Lee, K. M.; Koo, J. S.; Jung, Y.; Lee, B. J.; Yoon, H.; Kim, H. W.; Lim, Y. J., et al.

ArticleIssue Date2024CitationJournal of Crohn's and Colitis, v.18, no.Supplement, pp I1007 - I1009PublisherOxford University Press
SCIESCOPUS
Predicted inflammatory status and Inflammatory Bowel Disease among Korean adults: a Multicentre case-control study

Kim, D. H.; Okekunle, A. P.; Kang, J.; Kim, H. S.; Kim, S. H.; Jung, M. K.; Park, J. H.; Na, S. Y.; Lee, J. E.; Lim, Y. J., et al.

ArticleIssue Date2024CitationJournal of Crohn's and Colitis, v.18, no.Supplement, pp i1673 - i1674PublisherOxford University Press
SCIESCOPUS
The Influence of positive family history on the phenotype and clinical course of inflammatory bowel disease: A Systematic review and meta-Analysis

Kim, Y.; Oh, D. J.; Han, S. J.; Park, J. J.

ArticleIssue Date2024CitationJournal of Crohn's and Colitis, v.18, no.Supplement, pp I2085 - I2085PublisherOxford University Press
SCIESCOPUS
An experience of anti-TNF biosimilar, CT-P13 use: clinical efficacy, safety and interchangeability in inflammatory bowel disease; a pilot studyopen access

Kang, H. W.; Lim, Y. J.; Kim, J. H.; Kang, Y. -S.

ArticleIssue Date2014CitationJOURNAL OF CROHNS & COLITIS, v.8, pp S303 - S303PublisherOXFORD UNIV PRESS
SCIESCOPUS
Long-term clinical outcomes of Korean patients with Crohn's diseaseopen access

Choi, S. Y.; Kim, N. H.; Jung, Y. S.; Moon, C. M.; Lee, S. Y.; Kim, E. R.; Kim, Y. H.; Lee, C. K.; Lee, S. H.; Kim, J. H., et al.

ArticleIssue Date2014CitationJOURNAL OF CROHNS & COLITIS, v.8, pp S244 - S245PublisherOXFORD UNIV PRESS
1
CONTACT US

RSS_1.0 RSS_2.0 ATOM_1.0

30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114

Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어